UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                        Washington, D.C. 20549


                             SCHEDULE 13G

               Under the Securities Exchange Act of 1934


                           (Amendment No. )*


                          Castlight Health, Inc.
                             (Name of Issuer)

                           Class B Common Stock
                      (Title of Class of Securities)

                                14862Q100
                              (CUSIP Number)

                             October 31, 2014
         (Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).


















CUSIP: 14862Q100                                                Page 1 of 6



 1   NAMES OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
     Capital World Investors **


 2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE
     INSTRUCTIONS)                                                 (a)

                                                                    (b)
 3   SEC USE ONLY


 4   CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware

             5   SOLE VOTING POWER

                  1,529,167


             6   SHARED VOTING POWER
 NUMBER OF
   SHARES         NONE
BENEFICIALL
 Y OWNED BY
             7   SOLE DISPOSITIVE POWER
    EACH
 REPORTING        1,529,167
   PERSON
   WITH:
             8   SHARED DISPOSITIVE POWER

                  NONE

 9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     1,529,167          Beneficial ownership disclaimed pursuant to Rule
     13d-4


 10  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     (SEE INSTRUCTIONS)


 11  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     11.9%

 12  TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     IA

** A division of Capital Research and Management Company (CRMC)






CUSIP: 14862Q100                                                Page 2 of 6


                  SECURITIES AND EXCHANGE COMMISSION
                         Washington, DC 20549

                             Schedule 13G
               Under the Securities Exchange Act of 1934

Amendment No.

Item 1(a)     Name of Issuer:
       Castlight Health, Inc.

Item 1(b)     Address of Issuer's Principal Executive Offices:
       121 Spear Street, Suite 300
       San Francisco, CA 94105

Item 2(a)     Name of Person(s) Filing:
       Capital World Investors

Item 2(b)     Address of Principal Business Office or, if none,
       Residence:
       333 South Hope Street
       Los Angeles, CA 90071

Item 2(c)     Citizenship:   N/A

Item 2(d)     Title of Class of Securities:
       Class B Common Stock

Item 2(e)     CUSIP Number:
       14862Q100

Item 3     If this statement is filed pursuant to sections 240.13d-1(b)
       or 240.13d-2(b) or (c), check whether the person filing is a:
       (e)      [X]     An investment adviser in accordance with
            section 240.13d-1(b)(1)(ii)(E).

Item 4     Ownership

       Provide the following information regarding the aggregate
       number and percentage of the class of securities of the issuer
       identified in Item 1.


       (a)    Amount beneficially owned:
       (b)    Percent of class:
       (c)    Number of shares as to which the person has:
       (i)    Sole power to vote or to direct the vote:
       (ii)   Shared power to vote or to direct the vote:
       (iii)  Sole power to dispose or to direct the disposition of:
       (iv)   Shared power to dispose or to direct the disposition of:

       See page 2

       Capital World Investors is deemed to be the beneficial owner of
       1,529,167 shares or 11.9% of the 12,765,000 shares believed to
       be outstanding as a result of CRMC acting as investment adviser
       to various investment companies registered under Section 8 of
       the Investment Company Act of 1940.


CUSIP: 14862Q100                                                Page 3 of 6

Item 5     Ownership of Five Percent or Less of a Class.  If this
       statement is being filed to report the fact that as of the date
       hereof the reporting person has ceased to be the beneficial
       owner of more than five percent of the class of securities,
       check the following: [ ]

Item 6     Ownership of More than Five Percent on Behalf of Another
       Person: One or more clients of Capital World Investors have the
       right to receive or the power to direct the receipt of
       dividends from, or the proceeds from the sale of, the Class B
       Common Stock of Castlight Health, Inc..  Capital World
       Investors holds more than five percent of the outstanding Class
       B Common Stock of Castlight Health, Inc. as of October 31, 2014
       on behalf of each of the following client(s):

       SMALLCAP World Fund, Inc.

Item 7     Identification and Classification of the Subsidiary Which
       Acquired the Security Being Reported on By the Parent Holding
       Company or Control Person: N/A

Item 8     Identification and Classification of Members of the Group:
       N/A

Item 9     Notice of Dissolution of Group:  N/A

Item 10     Certification

       By signing below, I certify that, to the best of my knowledge
       and belief, the securities referred to above were acquired and
       are held in the ordinary course of business and were not
       acquired and are not held for the purpose of or with the effect
       of changing or influencing the control of the issuer of the
       securities and were not acquired and are not held in connection
       with or as a participant in any transaction having that purpose
       or effect.

     Signature

       After reasonable inquiry and to the best of my knowledge and
       belief, I certify that the information set forth in this
       statement is true, complete and correct.

        Date:          November 7, 2014

        Signature:     Alan Berro***
        Name/Title:    Alan Berro - Senior Vice President
                       Capital World Investors




        ***By  /s/ Michael J. Triessl
               Michael J. Triessl
               Attorney-in-fact

          Signed pursuant to a Power of Attorney dated September 18,
          2014 included as Exhibit to the Schedule 13G filed with the
          Securities and Exchange Commission by Capital World Investors
          on November 7, 2012 with respect to Castlight Health Inc.
CUSIP: 14862Q100                                                Page 4 of 6














                           POWER OF ATTORNEY

     The undersigned do hereby appoint Donald H. Rolfe and Michael J.
Triessl, and each of them, acting singly, with full power of
substitution, as the true and lawful attorney of the undersigned, to
sign on behalf of the undersigned in respect of the ownership of equity
securities deemed held by the undersigned, Capital World Investors,
American Balanced Fund, American High-Income Trust, The Bond Fund of
America, Inc., Capital International Global Growth, Capital
International Global Equity Fund, EuroPacific Growth Fund, American
Funds Fundamental Investors, The Growth Fund of America, The Income
Fund of America, International Growth and Income Fund, New Perspective
Fund, New World Fund, Inc., SMALLCAP World Fund, Inc., American Funds
Insurance Series (Asset Allocation Fund, Global Growth Fund, Global
Growth and Income Fund, New World Fund, Growth Fund), and Washington
Mutual Investors Fund, and to be reported pursuant to Sections 13(d)
13(f) and 13(g) of the Securities Exchange Act of 1934, as amended, and
to execute joint filing agreements with respect to such filings.

     IN WITNESS WHEREOF, this Power of Attorney has been executed as of
      th
the 18   day of September 2014.


Capital World Investors         Washington Mutual
                                Investors Fund

/s/ Alan N. Berro               /s/ Jennifer L. Butler
Name:      Alan N. Berro        Name:     Jennifer L.
                                Butler
Title:     Senior Vice          Title:     Secretary
President



American Balanced Fund          American High-Income
                                Trust
American Funds                  The Bond Fund of
Fundamental Investors           America, Inc.
The Growth Fund of
America
The Income Fund of              /s/ Courtney R. Taylor
America
EuroPacific Growth Fund         Name:     Courtney R.
                                Taylor
International Growth and        Title:     Secretary
Income Fund
New Perspective Fund
New World Fund, Inc.
CUSIP: 14862Q100                                                Page 5 of 6

SMALLCAP World Fund, Inc

/s/ Michael W. Stockton         American Funds Insurance
                                Series
Name:    Michael W.
Stockton
Title:     Secretary
                                /s/ Steven I. Koszalka
                                Name:     Steven I.
                                Koszalka
                                Title:     Secretary



















































CUSIP: 14862Q100                                                Page 6 of 6